Cell culture process scale-up challenges for commercial-scale manufacturing of allogeneic pluripotent stem cell products
In this communication article from Lee et al, the authors describe the challenges involved in the large scale manufacture of pluripotent stem cells from single-use bioreactors before discussing the solutions designed to address the bottlenecks in this process.
Delve into the full article, which sheds light on the optimization of seed culture production, the hydrodynamic conditions favorable to scale-up, harvesting processes and more.
To learn more about this innovative technology, visit PBS Biotech.
This article is part of the RegMedNet Spotlight on scaling up for cell and gene therapies. Click here to view the full feature and discover expert insights on this >>>
In association with
